Molecular survey of β-lactamases conferring resistance to newer β-lactams in Enterobacteriaceae isolates from Polish Hospitals

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 7, 2008, Pages 2449-2454

  Empel, Joanna ^a   Baraniak, Anna ^a   Literacka, Elzbieta ^a   Mrówka, Agnieszka ^a   Fiett, Janusz ^a   Sadowy, Ewa ^a   Hryniewicz, Waleria ^a   Gniadkowski, Marek ^a   Bakiera, J ^b   Budak, A ^c   Burdynowski, K ^d   Golec, K ^e   Jaworska Blach E ^f   Kochanowska, J ^g   Powarzynska A ^e   Ruszel, B ^h   Sobolewska, E ⁱ   Stankiewicz, D ^j   Szarata, M ^k   Ziolkowski G ^l   Zaglewska, B ^m   Zulikowski, W ^g   more..

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b Division of Surgery   (Poland)

^c University Hospital Krakow   (Poland)

^d Voivodship Hospital   (Poland)

^e Voivodship Hospital No 2   (Poland)

^f Voivodship Specialty Hospital   (Poland)

^g Voivodship Hospital   (Poland)

^h Voivodship Hospital   (Poland)

ⁱ St Barbara Voivodship Specialist Hospital ^*  (Poland)

^j Brodno Voivodship Hospital   (Poland)

^k Voivodship Hospital   (Poland)

^l Department of Rehabilitation   (Poland)

^m ST ADALBERT HOSPITAL   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE AMPC; CEPHALOSPORINASE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE SEQUENCE; GEOGRAPHIC DISTRIBUTION; HOSPITAL; KLEBSIELLA; NONHUMAN; NUCLEOTIDE SEQUENCE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEUS MIRABILIS; RANDOM AMPLIFIED POLYMORPHIC DNA; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CROSS INFECTION; DATA COLLECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; POLAND;

EID: 46449119823     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00043-08     Document Type: Article

References (37)

1. Baraniak, A., J. Fiett, W. Hryniewicz, P. Nordmann, and M. Gniadkowski. 2002. Ceftazidime-hydrolyzing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393-396.
2. Baraniak, A., J. Fiett, A. Sulikowska, W. Hryniewicz, and M. Gniadkowski. 2002. Countrywide spread of CTX-M-3 extended-spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob. Agents Chemother. 46:151-159.
3. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.
4. Beceiro, A., and G. Bou. 2004. Class C β-lactamases: an increasing problem worldwide. Rev. Med. Microbiol. 15:141-152.
5. Belaaouaj, A., C. Lapoumeroulie, M. M. Canica, G. Vedel, P. Névot, R. Krishnamoorthy, and G. Paul. 1994. Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2). FEMS Microbiol. Lett. 120:75-80.
6. Blázquez, J., M. R. Baquero, R. Cantón, I. Alos, and F. Baquero. 1993. Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob. Agents Chemother. 37:2059-2063.
7. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
8. Bradford, P. A. 2001. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14:933-951.
9. Bret, L., C. Chanal-Claris, D. Sirot, E. B. Chaibi, R. Labia, and J. Sirot. 1998. Chromosomally encoded AmpC-type β-lactamase in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 42:1110-1114.
10. Chaïbï, E. B., D. Sirot, G. Paul, and R. Labia. 1999. Inhibitor-resistant TEM β-lactamases: phenotypic, genetic and biochemical characteristics. J. Antimicrob. Chemother. 43:447-458.
11. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 17th informational supplement, M100-S17. CLSI, Wayne, PA.
12. Coudron, P. E., N. D. Hanson, and M. W. Climo. 2003. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases. J. Clin. Microbiol. 41:772-777.
13. D'Andrea, M. M., E. Nucleo, F. Luzzaro, T. Giani, R. Migliavacca, F. Vailati, V. Kroumova, L. Pagani, and G. M. Rossolini. 2006. CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy. Antimicrob. Agents Chemother. 50:618-624.
14. Dubois, V., L. Poirel, C. Arpin, L. Coulange, C. Bebear, P. Nordmann, and C. Quentin. 2004. SHV-49, a novel inhibitor-resistant β-lactamase in a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 48:4466-4469.
15. Edelstein, M., M. Pimkin, I. Palagin, I. Edelstein, and L. Stratchounski. 2003. Prevalence and molecular epidemiology of CTX-M extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob. Agents Chemother. 47:3724-3732.
16. Fiett, J., A. Pałucha, B. Mia̧czyńska, M. Stankiewicz, H. Przondo-Mordarska, W. Hryniewicz, and M. Gniadkowski. 2000. A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase-producing klebsiellae. Antimicrob. Agents Chemother. 44:1499-1505.
17. Galas, M., J.-W. Decousser, N. Breton, T. Godard, P. Y. Allouch, P. Pina, and the Collège de Bactériologie Virologie Hygiène (ColBVH) Study Group. 2008. Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae in France. Antimicrob. Agents Chemother. 52:786-789.
18. Gniadkowski, M., I. Schneider, R. Jungwirth, W. Hryniewicz, and A. Bauernfeind. 1998. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM and SHV-5-type extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42:514-520.
19. Gniadkowski, M., I. Schneider, A. Pałucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.
20. CTX-M-3. Antimicrob. Agents Chemother. 51:3789-3795.
21. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430.
22. Hernández, J. R., L. Martínez-Martínez, R. Cantón, T. M. Coque, A. Pascual, and the Spanish Group for Nosocomial Infections (GEIH). 2005. Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain. Antimicrob. Agents Chemother. 49:212-2125.
23. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
24. Jeong, S. H., I. K. Bae, J. H. Lee, S. G. Sohn, G. H. Kang, G. J. Jeon, Y. H. Kim, B. C. Jeong, and S. H. Lee. 2004. Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli from a Korean nationwide survey. J. Clin. Microbiol. 42:2902-2906.
25. Literacka, E., J. Empel, A. Baraniak, E. Sadowy, W. Hryniewicz, and M. Gniadkowski. 2004. Four variants of the Citrobacter freundii AmpC-type cephalosporinases, including two novel enzymes, CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob. Agents Chemother. 48:4136-4143.
26. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
27. Livermore, D. M., R. Cantón, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.
28. Luzzaro, F., M. Mezzatesta, C. Mugnaioli, M. Perilli, S. Stefani, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2006. Trends in production of extended-spectrum β-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J. Clin. Microbiol. 44:1659-1664.
29. Mabilat, C., S. Goussard, W. Sougakoff, R. C. Spencer, and P. Courvalin. 1990. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 23:27-34.
30. Migliavacca, R., E. Nucleo, M. M. D'Andrea, M. Spalla, T. Giani, and L. Pagani. 2007. Acquired AmpC type β-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities. New Microbiol. 30:295-298.
31. Molland, E. S., N. D. Hanson, J. A. Black, A. Hossain, W. Song, and K. S. Thomson. 2006. Prevalence of newer β-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002. J. Clin. Microbiol. 44:3318-3324.
32. Mulvey, M. R., E. Bryce, D. Boyd, M. Ofner-Agostini, S. Christianson, A. E. Simor, S. Paton, and The Canadian Hospital Epidemiology Committee of The Canadian Nosocomial Infection Surveillance Program, Health Canada. 2004. Ambler class A extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 48:1204-1214.
33. Nicolas-Chanoine, M. H. 1997. Inhibitor-resistant β-lactamases. J. Antimicrob. Chemother. 40:1-3.
34. Pérez-Pérez, F. J., and N. D. Hanson. 2002. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
35. Philippon, A., G. Arlet, and G. A. Jacoby. 2002. Plasmid-determined AmpC-type β-lactamases. Antimicrob. Agents Chemother. 46:1-11.
36. Renders, N., A. van Belkum, A. Barth, W. Goessens, J. Mouton, and H. Verbrugh. 1996. Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clin. Microbiol. Infect. 1:261-265.
37. Yan, J. J., P. R. Hsueh, J. J. Lu, F. Y. Chang, J. M. Shyr, J. H. Wan, Y. C. Liu, Y. C. Chuang, Y. C. Yang, S. M. Tsao, H. H. Wu, L. S. Wang, T. P. Lin, H. M. Wu, H. M. Chen, and J. J. Wu. 2006. Extended-spectrum β-lactamases and plasmid-mediated AmpC enzymes among clinical isolates of Escherichia coli and Klebsiella pneumoniae from seven medical centers in Taiwan. Antimicrob. Agents Chemother. 50:1861-1864.